Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals

Previously published guidelines are available that provide comprehensive recommendations for detecting and preventing healthcare-associated infections. The intent of this document is to highlight practical recommendations in a concise format designed to assist acute care hospitals in implementing and prioritizing their Clostridium difficile infection (CDI) prevention efforts. Refer to the Society for Healthcare Epidemiology of America/Infectious Diseases Society of America “Compendium of Strategies to Prevent Healthcare-Associated Infections” Executive Summary and Introduction and accompanying editorial for additional discussion. 1. Increasing rates of CDI C. difficile now rivals methicillin-resistant Staphylococcus aureus (MRSA) as the most common organism to cause healthcare-associated infections in the United States. a. In the United States, the proportion of hospital discharges in which the patient received the International Classification of Diseases, Ninth Revision discharge diagnosis code for CDI more than doubled between 2000 and 2003, and CDI rates continued to increase in 2004 and 2005 (L. C. McDonald, MD, personal communication, July 2007). These increases have been seen in pediatric and adult populations, but elderly individuals have been disproportionately affected. CDI incidence has also increased in Canada and Europe. b. There have been numerous reports of an increase in CDI severity. c. Most reports of increases in the incidence and severity of CDI have been associated with the BI/NAP1/027 strain of C. difficile. This strain produces more toxins A and B in vitro than do many other strains of C. difficile, produces a third toxin (binary toxin), and is highly resistant to fluoroquinolones.

[1]  John M Boyce,et al.  Impact of Hydrogen Peroxide Vapor Room Decontamination on Clostridium difficile Environmental Contamination and Transmission in a Healthcare Setting , 2008, Infection Control & Hospital Epidemiology.

[2]  M. Loeb,et al.  Infection Control and Hospital Epidemiology Clostridium Difficile in Long-term–care Facilities for the Elderly Shea Position Paper , 2022 .

[3]  David W Bates,et al.  Safety of patients isolated for infection control. , 2003, JAMA.

[4]  R. Weinstein,et al.  Risk of Hand or Glove Contamination After Contact With Patients Colonized With Vancomycin-Resistant Enterococcus or the Colonized Patients' Environment , 2008, Infection Control & Hospital Epidemiology.

[5]  B. Hota,et al.  Multicenter Study of the Impact of Community-Onset Clostridium difficile Infection on Surveillance for C. difficile Infection , 2009, Infection Control & Hospital Epidemiology.

[6]  T. Pallasch,et al.  Clostridium difficile-associated diarrhea and colitis. , 1999, Journal of the California Dental Association.

[7]  K. Kaier,et al.  Two Time-Series Analyses of the Impact of Antibiotic Consumption and Alcohol-Based Hand Disinfection on the Incidences of Nosocomial Methicillin-Resistant Staphylococcus aureus Infection and Clostridium difficile Infection , 2009, Infection Control & Hospital Epidemiology.

[8]  A. Bader,et al.  Proposed Checklist of Hospital Interventions to Decrease the Incidence of Healthcare-Associated Clostridium difficile Infection , 2009, Infection Control & Hospital Epidemiology.

[9]  Melinda B Davis,et al.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  P. Carling,et al.  Identifying Opportunities to Enhance Environmental Cleaning in 23 Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.

[11]  A. Barkun,et al.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. , 2005, JAMA.

[12]  L. Sehulster,et al.  Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[13]  B. Limbago,et al.  Complete Restriction of Fluoroquinolone Use to Control an Outbreak of Clostridium difficile Infection at a Community Hospital , 2009, Infection Control & Hospital Epidemiology.

[14]  V. Fraser,et al.  Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. , 2007, American journal of infection control.

[15]  G. D'Angelo,et al.  Attributable Outcomes of Endemic Clostridium difficile–associated Disease in Nonsurgical Patients , 2008, Emerging infectious diseases.

[16]  M. Kollef,et al.  Surveillance for Vancomycin-Resistant Enterococci: Type, Rates, Costs, and Implications , 2006, Infection Control & Hospital Epidemiology.

[17]  Yan Yan,et al.  Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  F. Gordin,et al.  Reduction in Nosocomial Transmission of Drug-Resistant Bacteria After Introduction of an Alcohol-Based Handrub , 2005, Infection Control & Hospital Epidemiology.

[19]  L. Peterson,et al.  Nosocomial Clostridium difficile colonisation and disease , 1990, The Lancet.

[20]  M. Owings,et al.  Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–2003 , 2006, Emerging Infectious Diseases.

[21]  D. Gerding,et al.  Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007. , 2009, Anaerobe.

[22]  Patricia Muñoz,et al.  Saccharomyces cerevisiae fungemia: an emerging infectious disease. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  L. Peterson,et al.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. , 1992, The Journal of infectious diseases.

[24]  Jeanne E. Zack,et al.  Use of Hypochlorite Solution to Decrease Rates of Clostridium difficile-Associated Diarrhea , 2007, Infection Control & Hospital Epidemiology.

[25]  Carlene A. Muto,et al.  A Large Outbreak of Clostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use , 2005, Infection Control & Hospital Epidemiology.

[26]  Teresa C Horan,et al.  Guidance on Public Reporting of Healthcare-Associated Infections: Recommendations of the Healthcare Infection Control Practices Advisory Committee , 2005, Infection Control & Hospital Epidemiology.

[27]  K. Kizer.  The national quality forum , 2001 .

[28]  D. Warren,et al.  Identification of a Pseudo-Outbreak of Clostridium difficile Infection (CDI) and the Effect of Repeated Testing, Sensitivity, and Specificity on Perceived Prevalence of CDI , 2009, Infection Control & Hospital Epidemiology.

[29]  J. Garner,et al.  Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. , 1996, Infection control and hospital epidemiology.

[30]  L. Valiquette,et al.  Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  L. Peterson,et al.  Treatment of Asymptomatic Clostridium difficile Carriers (Fecal Excretors) with Vancomycin or Metronidazole , 1992, Annals of Internal Medicine.

[32]  Bala N Hota,et al.  Comparison of the Efficacy of a Hydrogen Peroxide Dry-Mist Disinfection System and Sodium Hypochlorite Solution for Eradication of Clostridium difficile Spores , 2009, Infection Control & Hospital Epidemiology.

[33]  W. Stamm,et al.  Nosocomial acquisition of Clostridium difficile infection , 1990 .

[34]  M. Jackson,et al.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings , 2007, American Journal of Infection Control.

[35]  A. Kneebone,et al.  Surgical management of colorectal cancer in south‐western Sydney 1997−2001: a prospective series of 1293 unselected cases from six public hospitals , 2005, ANZ journal of surgery.

[36]  J. Garner.  Guideline for isolation precautions in hospitals. , 1996 .

[37]  J. Boyce,et al.  Lack of Association Between the Increased Incidence of Clostridium difficile–Associated Disease and the Increasing Use of Alcohol-Based Hand Rubs , 2006, Infection Control & Hospital Epidemiology.

[38]  Victoria J. Fraser,et al.  ICD-9 Codes and Surveillance for Clostridium difficile–associated Disease , 2006, Emerging infectious diseases.

[39]  D. Gerding,et al.  Decrease in Nosocomial Clostridium difficileAssociated Diarrhea by Restricting Clindamycin Use , 1994, Annals of Internal Medicine.

[40]  D. Musher,et al.  Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  M. Beaulieu,et al.  Risk of Clostridium difficile-Associated Disease Among Patients Receiving Proton-Pump Inhibitors in a Quebec Medical Intensive Care Unit , 2007, Infection Control & Hospital Epidemiology.

[42]  Jon Brazier,et al.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe , 2005, The Lancet.

[43]  R. Feldman,et al.  Clostridium difficile and gastroenteritis: how strong is the association in children? , 1984, Pediatric Infectious Disease.

[44]  Didier Pittet,et al.  Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. , 2002, American journal of infection control.

[45]  K. Wilson,et al.  Acquisition of Clostridium difficile from the hospital environment. , 1988, American journal of epidemiology.

[46]  J. Gammon,et al.  The pros and cons of isolation and containment. , 1999, The Journal of hospital infection.

[47]  J Jaime Caro,et al.  The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. , 2007, Infection control and hospital epidemiology.

[48]  L. McDonald.  Confronting Clostridium difficile in inpatient health care facilities. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  C. Kelly,et al.  Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  Mark A. Miller,et al.  Morbidity, Mortality, and Healthcare Burden of Nosocomial Clostridium Difficile-Associated Diarrhea in Canadian Hospitals , 2002, Infection Control & Hospital Epidemiology.

[51]  L. Lanthier,et al.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  Lynne V McFarland,et al.  Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease , 2002, American Journal of Gastroenterology.

[53]  J. Schrenzel,et al.  Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. , 2008, The Journal of antimicrobial chemotherapy.

[54]  J. Siegel,et al.  HEALTH CARE INFECTION CONTROL PRACTICES ADVISORY COMMITTEE. 2007 GUIDELINE FOR ISOLATION PRECAUTIONS: PREVENTING TRANSMISSION OF INFECTIOUS AGENTS IN HEALTH CARE SETTINGS , 2007 .

[55]  M. Samore,et al.  Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. , 1996, The American journal of medicine.

[56]  R. Freeman,et al.  National Clostridium difficile Standards Group: Report to the Department of Health. , 2004, The Journal of hospital infection.

[57]  T. Horan,et al.  Recommendations for Surveillance of Clostridium difficile–Associated Disease , 2007, Infection Control & Hospital Epidemiology.

[58]  Curtis J Donskey,et al.  What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. , 2009, American journal of infection control.

[59]  E. Kuijper,et al.  Emergence of Clostridium difficile-associated disease in North America and Europe. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[60]  Didier Pittet,et al.  Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Dis , 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[61]  E. Wong,et al.  Public Disclosure of Healthcare-Associated Infections: The Role of the Society for Healthcare Epidemiology of America , 2005, Infection Control & Hospital Epidemiology.

[62]  M. Wilcox,et al.  Value of lysozyme agar incorporation and alkaline thioglycollate exposure for the environmental recovery of Clostridium difficile. , 2000, The Journal of hospital infection.

[63]  J. Stockman.  A Predominantly Clonal Multi-Institutional Outbreak of Clostridium difficile—Associated Diarrhea With High Morbidity and Mortality , 2007 .

[64]  Stuart Johnson,et al.  An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.

[65]  L. Valiquette,et al.  Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec , 2005, Canadian Medical Association Journal.

[66]  J. Boyce,et al.  Monitoring the Effectiveness of Hospital Cleaning Practices by Use of an Adenosine Triphosphate Bioluminescence Assay , 2009, Infection Control & Hospital Epidemiology.

[67]  M. Kollef,et al.  Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000–2005 , 2008, Emerging infectious diseases.

[68]  Valerie Smith,et al.  Prospective, Controlled, Cross-Over Trial of Alcohol-Based Hand Gel in Critical Care Units , 2008, Infection Control & Hospital Epidemiology.

[69]  C. Donskey,et al.  Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  J. Colaert,et al.  Significance of Clostridium difficile and its cytotoxin in children , 1986, European Journal of Pediatrics.

[71]  R. Möllby,et al.  Intestinal colonization withClostridium difficile in infants up to 18 months of age , 1989, European Journal of Clinical Microbiology and Infectious Diseases.

[72]  M. Olsen,et al.  Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[73]  K. Nelson,et al.  The role of physical proximity in nosocomial diarrhea. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  B. Cooper,et al.  The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. , 2007, The Journal of antimicrobial chemotherapy.

[75]  B S Cooper,et al.  Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. , 2007, The Journal of antimicrobial chemotherapy.

[76]  J. Dolovich,et al.  The need for extended treatment of anaphylaxis. , 1980, Canadian Medical Association journal.

[77]  A AlAbdukareem.  Randomized, placebo-controlled trial. , 2004 .

[78]  J. Pépin,et al.  Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[79]  W. Graninger,et al.  Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[80]  S. Sattar,et al.  Activity of selected oxidizing microbicides against the spores of Clostridium difficile: relevance to environmental control. , 2005, American journal of infection control.

[81]  M. Wilcox,et al.  Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. , 2003, The Journal of hospital infection.

[82]  A. Jeanes,et al.  Marketing hand hygiene in hospitals--a case study. , 2002, The Journal of hospital infection.

[83]  C. Donskey,et al.  Persistence of Skin Contamination and Environmental Shedding of Clostridium difficile during and after Treatment of C. difficile Infection , 2010, Infection Control & Hospital Epidemiology.

[84]  R. Fekety.  Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. , 1997, The American journal of gastroenterology.

[85]  Sanjay Saint,et al.  Do physicians examine patients in contact isolation less frequently? A brief report. , 2003, American journal of infection control.

[86]  F. Weaver,et al.  Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. , 2007, The Journal of infection.

[87]  M. Marks,et al.  Is Clostridium difficile pathogenic in infants? , 1982, The Journal of pediatrics.

[88]  C. Surawicz,et al.  The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[89]  T. Leet,et al.  Environmental control to reduce transmission of Clostridium difficile. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[90]  Nandini Dendukuri,et al.  Hand Hygiene with Soap and Water Is Superior to Alcohol Rub and Antiseptic Wipes for Removal of Clostridium difficile , 2009, Infection Control & Hospital Epidemiology.

[91]  M. Jackson,et al.  Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. , 2007 .

[92]  A. Harris,et al.  The use and interpretation of quasi-experimental studies in infectious diseases. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[93]  Ken Dewar,et al.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.

[94]  E. Kuijper,et al.  European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.